Company
Last deal
$2M
Amount
Post-IPO Equity
Stage
01.12.2023
Date
4
all rounds
$10.8M
Total amount
General
About Company
Kazia Therapeutics is an oncology-focused biotech company developing innovative anti-cancer drugs.
Industry
Sector :
Subsector :
Keywords :
Also Known As
Novogen
founded date
01.01.1994
Number of employees
Company Type
For Profit
Last funding type
Post-IPO Equity
IPO status
Private
Contacts
location
Phone number
Website URL